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Embryonic transplantP190A and p190B Rho GTPase activating proteins (GAPs) are essential genes that have distinct, but overlapping
roles in the developing nervous system. Previous studies from our laboratory demonstrated that p190B is
required for mammary gland morphogenesis, and we hypothesized that p190A might have a distinct role in
the developing mammary gland. To test this hypothesis, we examined mammary gland development in
p190A-deﬁcient mice. P190A expression was detected by in situ hybridization in the developing E14.5 day em-
bryonic mammary bud and within the ducts, terminal end buds (TEBs), and surrounding stroma of the develop-
ing virgin mammary gland. In contrast to previous results with p190B, examination of p190A heterozygous
mammary glands demonstrated that p190A deﬁciency disrupted TEB morphology, but did not signiﬁcantly
delay ductal outgrowth indicating haploinsufﬁciency for TEB development. To examine the effects of homozy-
gous deletion of p190A, embryonic mammary buds were rescued by transplantation into the cleared fat pads
of SCID/Beige mice. Complete loss of p190A function inhibited ductal outgrowth in comparison to wildtype
transplants (51% vs. 94% fat pad ﬁlled). In addition, the transplantation take rate of p190A deﬁcient whole
gland transplants from E18.5 embryos was signiﬁcantly reduced compared to wildtype transplants (31% vs.
90%, respectively). These results suggest that p190A function in both the epithelium and stroma is required
for mammary gland development. Immunostaining for p63 demonstrated that the myoepithelial cell layer is
disrupted in the p190A deﬁcient glands, which may result from the defective cell adhesion between the cap
and body cell layers detected in the TEBs. The number of estrogen- and progesterone receptor-positive cells,
as well as the expression levels of these receptors was increased in p190A deﬁcient outgrowths. These data
suggest that p190A is required in both the epithelial and stromal compartments for ductal outgrowth and that
it may play a role in mammary epithelial cell differentiation.eckman-Stoddard),
m.edu (M.P. Herrick),
.T. Lewis),
.edu (J.M. Rosen).
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Rho GTPases regulate a diverse set of biological activities including
actin organization, focal complex/adhesion assembly, cell motility,
cell polarity, gene transcription, differentiation, and cell cycle pro-
gression. Aberrant Rho GTPase expression and activation is known
to be involved in breast cancer development (Boettner and Van Aelst,
2002; Fritz et al., 1999, 2002; Sahai and Marshall, 2002; Schnelzer
et al., 2000). The mechanisms implicated in the deregulation of Rho
GTPases are indirect, requiring changes in Rho regulatory proteins,
which regulate the cycle between the GTP-bound active form and theGDP-bound inactive form. Guanine nucleotide exchange factors
(GEFs) exchange the bound GDP for GTP and return the GTPase to the
active state, while Rho GTPase activating proteins (RhoGAPs) enhance
the hydrolysis of the bound GTP.
Of the large RhoGAPs, themostwidely studied are the p190RhoGAPs.
Two isoforms of p190 exist, p190A, a putative tumor suppressor and
p190B, a putative oncogene (Heckman-Stoddard et al., 2009; McHenry
et al., 2010; Wang et al., 1997). These two genes, which share 51%
amino acid identity, map to different chromosomes suggesting they
diverged early in evolution acquiring distinct functions (Scheffzek
et al., 1998).
The functions of p190A have been investigated both in cell culture
and in vivo in p190A deﬁcient mice. P190A deﬁciency in mice results
in perinatal lethality due to defects in central nervous system (CNS)
development. These mice exhibit extensive neural cell adhesion de-
fects indicating that p190A plays a critical role in cell adhesion
(Brouns et al., 2000). Furthermore, extensive accumulation of
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mutant embryos, indicating that p190A is an important regulator of
the actin cytoskeleton. These studies also resulted in identiﬁcation
of p190A as a substrate of protein kinase C (PKC) due to similar phe-
notypes observed in the p190A mutant and MARCKS null mice, a
known substrate of PKC (Brouns et al., 2000). Despite these defects,
mouse embryonic ﬁbroblasts (MEFs) from p190A mutant embryos
exhibit normal proliferation rates, morphology, actin organization,
migration, spreading, and adhesion to extracellular matrix. This is
thought to be due to abundant p190B in these cells, which was previ-
ously shown to account for 5-times the level of the RhoGAP activity of
p190A in ﬁbroblasts (Vincent and Settleman, 1999). However, recent
studies have shown that p190A-null ﬁbroblasts are defective in direc-
tional motility, and p190A along with RhoA was shown to act down-
stream of the PAR-6/aPKC complex in regulating dentritic-spine
polarity (Jiang et al., 2008; Zhang and Macara, 2008). P190A further
regulates polarity by affecting focal adhesion maturation and inter-
acting with p120RasGAP downstream of FAK at the leading edge of ﬁ-
broblasts during polarized cell migration (Pullikuth and Catling, 2010;
Tomar et al., 2009). P190A has also been shown to indirectly regulate
gene expression by affecting release of the transcription factor TFII-I,
allowing it to translocate to the nucleus to activate gene transcription
(Chang et al., 1995; Jiang et al., 2005). A role for p190A in cytokinesis
was indicated by its overexpression in MDA-MB-468 cells, which
blocked cytokinesis (Mikawa et al., 2008; Su et al., 2003).
In the developing mammary gland, p190B completely prevents
ductal outgrowth demonstrating that it is critical for normal develop-
ment. Consistent with these results, p190B heterozygous virgin mice
demonstrate delayed ductal morphogenesis during weeks 3–6 of
postnatal development as well as reduced tumor penetrance and
delayed tumor onset when crossed to the MMTV–Neu mammary
tumor model (Chakravarty et al., 2003; Heckman-Stoddard et al.,
2009). Conversely, overexpression of p190B in the mammary epitheli-
um during virgin development disrupts TEB morphogenesis, increases
side branching, and delays ductal elongation. This overexpression dur-
ing pregnancy results in hyperplastic lesions (Vargo-Gogola et al.,
2006). In the MMTV–Neu tumor model, p190B overexpression leads
to a 2-fold increase in tumormultiplicity, and a 3-fold increase inmetas-
tasis (McHenry et al., 2010). P190B is also required for embryonic
mammary development, and it plays an important role in both the
epithelial and stromal compartments of the developing mammary
bud. Deﬁciency of p190B results in a reduced number of epithelial
cells, and the mesenchyme surrounding the buds is disorganized and
diminished due to decreased proliferation. Similarities between these
developmental defects and those that result from loss of both IRS-1
and IRS-2 expression suggested a role for crosstalk of IGFR and p190B
signaling in embryonicmammary development (Heckman et al., 2007).
Investigation of the roles of p190A and p190B in CNS development
demonstrated that these two genes are required for CNS development
and that they have overlapping, but distinct functions (Matheson
et al., 2006). Therefore, we hypothesized that p190A, like p190B, is
required for mammary gland development, and if so, that it may play
a distinct role in regulating TEB morphogenesis and ductal outgrowth.
We examined the expression of p190A and tested the effects of loss of
p190A function on mammary gland development. The data reported
here conﬁrm that p190A is indeed required formammary development
and that it exerts unique effects distinct from p190B in regulating
mammary morphogenesis.
Materials and methods
Mouse strains
P190A null mice, generated in the laboratory of Dr. Jeffrey Settleman
(Harvard Medical School, Cambridge, MA), were maintained on a
CD1×C57Bl/6×129 Sv background. Mice were fed a conventional dietad libitum and maintained at 21–22 C with a 12 h light cycle, 12 h
dark cycle. Animal protocols were approved by the Animal Care and
Use Committee of Baylor College of Medicine and were conducted in
accordance with the provisions of the Guide for the Care and Use of
Laboratory Animals and the Animal Welfare Act. Wildtype females
werematedwith heterozygousmales for virginmammary gland devel-
opment studies.Wildtype littermateswere used as controls. Mice at ap-
propriate age were injected with BrdU (100 mg/kg) intraperitoneally.
Two hours later mammary glands (MGs) were dissected and ﬁxed for
2 h in 4% paraformaldehyde (PFA). MGs were dehydrated and embed-
ded in parafﬁn. Five μm serial sections were then taken in the frontal
plane. To obtain embryonic mammary tissue for transplantation experi-
ments, heterozygous femaleswerematedwith heterozygousmaleswith
detectionwith detection of a plugmarked as E1. At E18.5, embryoswere
dissected by Cesarean section, stored at 4 °C in DMEM/F12, genotyped
overnight for p190A (Matheson et al., 2006) and SRY (Chakravarty
et al., 2003), and dissected the following morning to isolate the nos. 3
and 4 embryonic fat pads containing the rudimentary ductal tree.In situ hybridization
Riboprobes were labeled with [DIG]-UTP (Boehringer 1277073),
using T7 transcription system from Stratagene. To generate antisense
riboprobe template, p190B cDNA was ampliﬁed from mouse brain by
PCR using forward primer 5′-GGATCCTAATACGACTCACTATAGGGAGA-
TATACTCGGTGCCCCACGACA and reverse primer 5′-CTCTGGAGTCAC-
CACTGTTGT. The sense riboprobe template was generated from the
same cDNA by PCR using forward primer 5′-TATACTCGGTGCCCCAC-
GACA and reverse primer 5′-GGATCCTAATACGACTCACTATAGGGA-
GACTCTGGAGTCACCACTGTTGT. Embryos were stained as previously
described (Heckman et al., 2007).
For mammary gland sections: 5 μm parafﬁn sections of 6 week old
mammary glands were deparafﬁnized, rehydrated and washed in
PBS. Then treated with PK (25 μg/ml) for 15 min at 37 °C and ﬁxed
with 4% PFA for 30 min followed by washing with 2×SSC. Pre-
warmed hybridization buffer containing the probe at a concentration
of 1 μg/ml was added and hybridized overnight at 55 °C. Slides were
washed with stringency wash (50% 2×SSC, 50% formamide) for
15 min at 42 °C followed by washes with 2×SSC 20 min at RT and di-
gestion with 40 μg/ml of RNase A for 15 min at 37 °C then washed
with 0.1×SSC for 15 min at 42 °C and then 10 min at RT. Slides were
then washed with Buffer I (100 mM Tris pH 7.5, 150 mM NaCl) for
5 min at RT and blocked for 2 h in Buffer I with 3% sheep serum and
0.3% triton X-100 at RT. The slides were then incubated overnight
with 1:200 anti-digoxigenin(DIG)-AP at 4 °C. For color development
slides were washed with Buffer I for 10 min at RT and then washed
with Buffer II (100 mM Tris pH9.5, 100 mM NaCl, 50 mM MgCl) for
2 min at RT and incubating them in prewarmed BM purple (Roche
1442074) from 30 min to overnight in the dark at RT. Slides were
counterstained with nuclear fast red, dehydrated, and mounted
using Permount (Sigma, St. Louis, MO).Whole mounts
VirginMGswere prepared as stainedwholemounts using hematox-
ylin as previously described (Chakravarty et al., 2003). Transplant MGs
were stained with Neutral Red (Landua et al., 2009). Brieﬂy, glands
were washed with acetone 3 times for 1 h each followed by overnight
staining with 10% Neutral Red/1% Acetic Acid (Moraes et al., 2007).
The following morning glands were washed with 100% EtOH 3 times
for 30 min, and cleared in xylene overnight. Pictures are captured in
the samemanner as hematoxylinwholemounts using a Leica stereomi-
croscope. Neutral Red stained glands are then embedded and sectioned
as described above to use for immunostaining.
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Because p190A heterozygous mice were in a mixed background,
immuno-compromised 3 week-old SCID/Beige mice (Charles River)
were employed as hosts to avoid graft rejection. Both of the inguinal
mammary glands were cleared of endogenous epithelium. Wildtype
inguinal embryonic epithelial fragments were implanted into an inci-
sion made in the cleared fat pad of the recipient gland, with a p190A
deﬁcient embryonic epithelial fragment from a littermate placed into
the contralateral gland. Thoracic embryonic glands were placed in
the interstitial space between the host thoracic and inguinal gland.
Mammary gland outgrowths were analyzed 6 weeks after transplan-
tation by whole mount staining.
Immunohistochemistry/immunoﬂuorescence
Immunohistochemistry for p63 (Labvision Thermo Fisher), netrin
and neogenin (Santa Cruz Biotechnology, Santa Cruz, CA), ERα
(Santa Cruz Biotechnology), and PR (Dako, Carpenteria, CA) was per-
formed as previously described (Vargo-Gogola et al., 2006). Immuno-
ﬂuorescence was performed using antibodies recognizing cytokeratin
8 (CK8) (Developmental Studies Hybridoma Bank, University ofAntisense p190A
Em
br
yo
ni
c 
bu
d
C
TE
B
D
uc
t
A
E
Fig. 1. p190A is expressed throughout embryonic and virgin mammary gland development. Spa
labeled antisense riboprobe and counter stained with fast red nuclear stain. Shown are repr
epithelial compartment of the mammary bud and lower expression in the mesenchyme and
Shown are representative images of TEB (C) and duct (E) demonstrating strong expressio
expression. Scale bar 50 μm.Iowa) cytokeratin 14 (CK14) (Covance) 1:200/1:200 in 5% BSA, 0.5%
blocking buffer plus MOM kit (Vector Laboratories) overnight at RT.
Sections were washed in PBS and incubated with anti-mouse Alexa
488 and anti-rabbit Alexa 594 (Invitrogen) secondary antibody dilut-
ed 1:250 in 5% BSA, 0.5% blocking buffer for 1 h at RT. Slides were
washed with PBS and staining according to the manufacturer's in-
structions with DAPI (Vector Laboratories). As a negative control,
slides were incubated with puriﬁed rabbit immunoglobulin (The
Jackson Laboratory). Masson's Trichrome (Sigma) was completed as
per the manufacturer guidelines.
Results
P190A is expressed in the developing embryonic and virgin mammary
gland
We previously reported that p190B is essential for mammary
gland development (Chakravarty et al., 2003). Because p190A and
p190B share 51% amino acid identity, we wanted to determine the ex-
pression patterns of p190A during mammary gland development.
Accordingly, we generated a DIG-labeled riboprobe to the more di-
vergent region of the p190A and p190B transcripts (no stretch ofSense control
D
B
F
tial localization of p190A mRNA in E14.5 mammary buds of wildtype mice using DIG-
esentative antisense (A) and sense (B) images with strong transcript expression in the
skin. Spatial localization of p190A mRNA within the developing virgin mammary gland.
n within both, and in the surrounding stroma. Sense control (D and F) is negative for
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that p190A, like p190B, is expressed within the epithelial compart-
ment of the E14.5 day embryonic mammary bud and at a lower
level in the surrounding stroma and skin (Fig. 1A). P190A is also
expressed throughout the TEB at comparable levels in both the body
and cap cells (Fig. 1C), in contrast to p190B, which is expressed at a
higher level in the cap cell layer (Chakravarty et al., 2000), conﬁrmed
using dig-labeled p190B probe (data not shown). p190A is also ob-
served in the ﬁbroblasts and stroma surrounding the TEB and uni-
formly throughout the ducts (Fig. 1C, E). No expression was
detected when sense control probes were used (Fig. 1B, D, F). These
results suggested that p190A, like p190B, may also play a role in em-
bryonic and virgin mammary gland development. There are currentlyA
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Fig. 2. p190A heterozygosity, unlike p190B, does not delay virgin outgrowth but does disrupt TEB
type (a) and p190A heterozygous (b) mice used to analyze the extent of ductal outgrowth.
recorded in millimeters (mm) for wildtype (black bar) and p190A heterozygous (red bar)
4 week time point, only (*pb .0001). C. Representative images of TEB from H&E-stained
Note the presence of dissociated cap cell layer (black arrow) and body cell layer (red ar
(black bar) and p190A heterozygous (red bar) mice is depicted by a graph. Note the signiﬁ
tative images of immunohistochemical staining for neogenin and netrin. Neogenin expression a
pared to wildtype TEBs (a). Netrin staining intensity is similar in wildtype (c) and p190A heteno antibodies for either p190A or p190B that detect protein expres-
sion in parafﬁn-embedded sections, and thus, these results could
not be conﬁrmed using immunohistochemical methods.
P190A heterozygosity transiently delays virgin outgrowth and disrupts
TEB architecture
Examination of mature p190A heterozygous females revealed no
overt defects during embryonic or postnatal mammary gland develop-
ment as well as no overt defects during lactation or involution. The het-
erozygous females are viable, gave birth to normal size litters, and
nursed their young. Examination of whole mounts of mammary glands
from virgin, midpregnant, and lactating mice did not reveal anyB-
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architecture. A. Whole mounted mammary glands from sister pairs of 4-week-old wild-
B. Using lymph node as a reference (indicated by LN), length of ductal outgrowth was
(n=5 per genotype per time point). Plot indicates signiﬁcantly reduced outgrowth at
mammary gland tissue sections from wildtype (a) or p190A heterozygous (b) mice.
row) in the p190A heterozygous TEB. D. The percentage of normal TEBs in wildtype
cant decrease in the number of normal TEBs at all time point (*pb .0001). E. Represen-
ppears to be decreased in the cap cell layer (arrows) of p190A heterozygous TEBs (b) com-
rozygous (d) TEBs.
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a delay in ductal outgrowth in early pubescent mice, we analyzed the
rate of ductal outgrowth at similar time points, 4, 5, and 6 weeks of
age in wildtype and heterozygous female littermates. P190A hetero-
zygous mice exhibited signiﬁcantly retarded growth at 4 weeks
(pb .0001) (Figs. 2Aa–b; B). However, this delay is no longer apparent
at 5 and 6 weeks (Fig. 2B and Supplementary Fig. 1a–b). To further in-
vestigate this early delay, we examined TEB histology in hematoxylin
& eosin (H&E) stained tissue sections. This analysis suggests that
p190A heterozygosity leads to a defect in adhesion between the cap
and body cell layers (black arrow) (Fig. 2C). To quantify the extent of
disruption the TEB structures, the percentage of normal TEB structures
was determined at 4, 5, and 6 weeks. Structureswere designated asnor-
mal if they did not show a disruption of the cap cell layer. In comparison
to wildtype, the percentage of normal TEB structures was signiﬁcantly
decreased in the p190A heterozygous glands (Fig. 2D), pb .0001 at allA
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Fig. 3. p190A is required in both the epithelium and the stroma for mammary morphogenesis. A
type (a) and p190A deﬁcient (b) embryos. Ductal epithelium is circled in red. B.Wholemount
Representative images are shown from epithelial fragment (EF) transplants and whole gland (W
average percentage of the fat pad ﬁlled. D. Graph depicting the transplantation take rates.time points (n=5 per time point; 50 TEBs analyzed). To further inves-
tigate the defect in adhesion between the cap and body cells, we per-
formed immunohistochemistry to examine expression patterns of the
axon guidance molecules netrin and neogenin that have been shown
to mediate cap and body cell adhesion (Srinivasan et al., 2003). Neo-
genin levels in the cap cell layer were reduced in p190A heterozygous
TEBs compared to wildtype TEBs (Figs. 2Ea–b), whereas netrin levels
were similar (Figs. 2Ec–d) (n=3miceper genotype; 15 TEBs analyzed).
These results indicate that p190A may play a role in early pubertal de-
velopment by affecting cell adhesion within the TEBs.
P190A is required in both the epithelium and stroma for mammary
morphogenesis
We next wanted to determine if complete loss of p190A would
inhibit mammary gland development. However, because homozygous-/-
p<.0001
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analysis ofmammary glands fromSCID/Beigemice harboring E18.5mammary transplants.
G) transplants of wildtype (a, c) and p190A deﬁcient (b, d) tissue. C. Graph depicting the
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2002), results in perinatal lethality (Brouns et al., 2000), rescue experi-
ments using embryonic tissue transplantation were required. Because
mammary gland development is critically dependent on stromal–
epithelial interactions (Parmar and Cunha, 2004; Streuli and Edwards,
1998), as well as systemic hormones, we used two types of transplanta-
tion techniques to determine if p190Awas important in the epithelium,
stroma, or both. Traditional epithelial fragment (EF) transplants were
done to examine the importance of p190A within the epithelium,
whereas whole gland (WG) transplants tested the role for p190A in
the combined epithelium and stroma. For this assay, EF andWG tissues
were isolated at 18.5 days of gestation and transplanted into the cleared
fat pad of SCID/beigemicewith opposing genotypes placed in contralat-
eral glands, or for the whole gland transplants within the interstitial
space between the contralateral endogenous thoracic and inguinal
glands of the host mouse. In all p190A genotypes, a rudimentary ductal
tree was present at E18.5 (Fig. 3A). After 6 weeks of outgrowth, 94% of
EF p190A+/+ transplants that grew out ﬁlled the entire fat pad with
normal ductal structures (Figs. 3Ba, c and Table 1). In contrast, p190A
deﬁciency inhibited ductal outgrowth, and on average, only 51% of the
fat pad was ﬁlled with ductal epithelium. These outgrowths also
displayed persistent TEB-like structures and/or rudimentary ductal
branching (Figs. 3Bb, d). The EF transplantation experiments revealed
that p190A is required in the mammary gland epithelium for ductal
outgrowth (Table 1), pb .0001. There was no signiﬁcant difference in
EF transplantation efﬁciencies (Table 1). However, p190A deﬁciency
signiﬁcantly reduced the WG transplantation efﬁciency (Table 1),
pb .0001. The WG transplants also displayed decreased outgrowth
potential (Table 1), pb .04. These results suggest that p190A is required
in both the epithelium and the stroma for proper ductal outgrowth.
P190A deﬁciency inhibits stromal condensation around mammary ducts
Histological analysis of the p190A EF transplants revealed a reduc-
tion in stromal condensation (black arrow) around the p190A-deﬁcient
ducts in comparison to p190A wildtype ducts (Figs. 4A–B). The stromal
defect was further demonstrated by a reduction in collagen around the
p190A-deﬁcient ducts (Fig. 4F) compared to wildtype (Fig. 4E) as
shown by Masson's Trichome staining, which stains collagen ﬁbrils
blue. Disrupted TEB-like structures are also present in the p190A-deﬁ-
cient transplants (Fig. 4D) compared to the wildtype transplants
(Fig. 4C). Although ﬁbroblasts were observed at the neck of the
p190A-deﬁcient TEBs (Fig. 4D, red arrow), they appear not to secreteTable 1
p190A deﬁciency in epithelium and stroma inhibits ductal outgrowth. Chart depicting the
types of transplants as well as % take rate including number of transplants and the av-
erage percentage of the fat pad ﬁlled based on successful transplants. Also included are
graphical representations of the extent of each transplant's outgrowth.
Genotype p190A+/+ p190A−/−
Type of
transplant
77% 90% 59% 31%
67%51%90%94%
24/31 28/31 13/22 7/22
Epithelial
fragment
Epithelial
fragment
Whole
gland
Whole
gland
%
take rate
Average %
fatpad filled
%
fatpad
filledcollagen to the in the same extent as the p190A wildtype ﬁbroblasts
(Fig. 4G, red arrow), as shown by the lack of blue staining (Fig. 4H,
red arrow). These results suggest that p190A deﬁciency in the epitheli-
um disrupts cross-talk with the stromal environment leading to im-
paired extracellular matrix deposition. In addition, these results are
consistent with the more pronounced defects seen in the WG trans-
plants and suggest that further impairment of extracellular matrix de-
position by p190A-deﬁcient stromal cells may contribute to this
phenotype.
Expression of steroid hormone receptors is altered in the p190A deﬁcient
glands
We next examined the expression of steroid receptors within the
transplants to determine if the lack of outgrowth was due to an in-
ability of the p190A-deﬁcient ducts to respond to hormonal stimula-
tion. Surprisingly, these studies revealed in increase the expression and
number of steroid receptor-positive cells. The number of estrogen
receptor α (ERα) positive cells was increased in the p190A-deﬁcient
transplants in comparison to p190A-wildtype transplants, pb .0001
(Figs. 5Aa–b, 4B). Because ERα and progesterone receptor (PR) co-
localize in more than 96% of normal breast epithelial cells, we also ex-
amine the expression of PR (Clarke et al., 1997). Similar to ERα, an
increase in the number of cells that express PR was detected, pb .0001
(Figs. 5Ac–d, 4C). However, no signiﬁcant changes in proliferation or
apoptosis were apparent within the ductal epithelium as determined
by number of BrdU- and cleaved caspase 3-positive cells, respectively.
These results suggest that p190A may play a role in the differentiation
of steroid hormone receptor-expressing cells.
P190A deﬁciency disrupts mammary architecture and alters mammary
gland differentiation
We next wanted to look at the cellular composition of the ductal
structures within the p190A deﬁcient outgrowths. We ﬁrst examined
the expression pattern of p63, a cap and myoepithelial cell marker.
This analysis revealed that there were fewer myoepithelial cells lining
the ducts in the p190A deﬁcient transplants in comparison to the
p190 wildtype transplants, which maintain a uniform layer of myoe-
pithelial cells around the ducts (Figs. 6A–B). We next examined the
expression of cytokeratin 8 (CK8) and cytokeratin 14 (CK14) by im-
munoﬂuorescence, which serve as markers of epithelial and myoe-
pithelial layers, respectively. Analysis of CK14 expression, like p63,
conﬁrmed that there are fewer myoepithelial cells underlying the lu-
minal epithelium (Figs. 6C–D, green), whereas no change in CK8 ex-
pression was detected (Figs. 6C–D, red). We also examined
expression of E-cadherin and smooth muscle actin (SMA), luminal
and myoepithelial cell markers, respectively (data not shown). Inter-
estingly, although the myoepithelial nuclei are spread further apart as
shown by the p63 staining, the CK14 and SMA staining pattern in the
p190A deﬁcient transplants suggests that the cells still interact to
form an intact myoepithelial cell layer (Figs. 6E–F, green). Consistent
with the K8 staining, E-cadherin expression was unaltered (data not
shown). These results in combination with the change in steroid hor-
mone receptor expression suggest that p190A is required for cell–cell
interactions that contribute to the differentiation of the mammary
epithelium.
Discussion
We observed that p190A, like p190B, is expressed throughout the
developing mammary gland and that its function is required for prop-
er mammary gland morphogenesis. Furthermore, our results suggest
that p190A plays a role in mediating cell adhesion within the TEB and
that complete loss of p190A leads to altered mammary gland differ-
entiation. These results suggest that p190A has similar, but distinct
Fig. 4. p190A deﬁciency inhibits stromal condensation around mammary ducts and disrupts steroid hormone receptor expression and pattern. Representative images of H&E-stained
ducts and TEBs from SCID/Beige mice transplanted with EF from mammary glands from wildtype (A, C) and p190A deﬁcient (B, D) mice. P190A-deﬁcient ducts lack stromal con-
densation (A, B black arrow) and have TEBs with loose stroma at the neck (C, D red arrow) compared to wildtype at 6 weeks post transplantation. Representative images of Mason's
Trichrome stain showing collagen ﬁbrils stained in blue. Reduced collagen deposition around the ducts of p190A deﬁcient ducts (F) compared to wildtype (E) (black arrow) and at
the neck of the p190A-deﬁcient TEB (H) compared to wildtype (G) (red arrow).
7B.M. Heckman-Stoddard et al. / Developmental Biology 360 (2011) 1–10roles from p190B within the mammary gland, as it does in the devel-
oping neural system (Matheson et al., 2006). For example, loss of one
allele of p190B delayed mammary gland outgrowth between 4 and
6 weeks, while heterozygosity for p190A did not signiﬁcantly delay
development past 4 weeks. The increased expression of p190B within
the cap cell layer may account for the difference in the outgrowth po-
tential, as the TEB is the driving force of ductal outgrowth due to the
high proliferative capacity of the cap cell layer (Chakravarty et al.,
2003; Humphreys et al., 1997).Interestingly, haploinsufﬁciency for p190A disrupts the TEB archi-
tecture resulting in adhesion defects within the cap cell layer and
body cell layer. Reduced levels of the axon guidance molecule neo-
genin, that is known to play an important role in cap and body cell ad-
hesion within TEBs (Srinivasan et al., 2003), may in part underlie the
adhesion defect. Other genes involved in axonal guidance, slit2/
robo1, have also been shown to play a role in adhesion with the TEB
and ducts of the developing mammary gland (Srinivasan et al.,
2003; Strickland et al., 2006). These proteins are members of the
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Fig. 5. Expression of steroid receptors is altered in the p190A-deﬁcient mammary glands. P190A-deﬁcient ducts have increased expression of ER (B) and PR (D) in number and level, in
comparison to wildtype ER (A) and PR (C) expression. B. Graphical representation of% of ER positive cells (pb .0001). C. Graphical representation of% of PR positive cells (pb .0001).
8 B.M. Heckman-Stoddard et al. / Developmental Biology 360 (2011) 1–10plexin family (Hinck, 2004). Interestingly, p190A deﬁcient ﬁbroblasts
are blocked or greatly impaired with respect to the typical functional
activities mediated by plexins, including cell collapse and inhibition
of integrin-based adhesion. Re-expression of wildtype p190A, but
not a mutant form speciﬁcally lacking RhoGAP activity, rescued
plexin-mediated functions in these cells (Barberis et al., 2005). Both
members of the p190 family have been shown to accumulate at
sites of integrin crosslinking, while only p190A has been shown to
function downstream of cadherin engagement suggesting a novel
mechanism through which p190A may be mediating this adhesion
defect (Burbelo et al., 1995; Noren et al., 2003; Sharma, 1998). Fur-
ther studies are required to determine the mechanisms by which
p190A regulates adhesion within the mammary gland.
P190A knockout mice die perinatally or just after birth due to de-
fects in forebrain midline structures (Brouns et al., 2000). At E18.5 the
p190A-deﬁcient embryonic mammary glands are indistinguishable
from those in wildtype littermates. We, therefore, used embryonic
mammary gland transplantation techniques to examine the effects
of complete loss of p190A on mammary gland development. The
use of both EF and WG transplants allowed us to investigate the
role of p190A in both the epithelium and stroma. These results
revealed p190A was important in both compartments as EF and WG
p190A-deﬁcient transplants demonstrated reduced outgrowth poten-
tial, andWGdeﬁcient transplants also displayed reduced transplantation
efﬁciency. Interestingly, the outgrowth potential is greater in the p190A-
deﬁcient glands than observed previously in the p190B-deﬁcient glands
(Chakravarty et al., 2003), suggesting that p190B may compensate for
some functions of p190A, while p190A appears not to compensate for
the loss of p190B. While these proteins normally may have some over-
lapping functions, a compensatory up regulation of p190B in the absence
of p190A has not been previously observed (Brouns et al., 2000).
Histological examination of p190A-deﬁcient EF transplants revealed
reduced stromal condensation around the ductal epithelium as well as
the persistence of TEB-like structures. This is in contrast to our studies
of p190B overexpression in the mammary gland where we have ob-
served an increase in stromal condensation (Vargo-Gogola et al.,
2006). This is of interest because activity of Rho kinase (ROK), a down-
streameffector, is required for breast epithelial cells to sense the rigidityof their environment and down regulate Rho activity to differentiate
(Wozniak et al., 2003). Thus, the lack of stromal condensation in the
p190A-deﬁcient glands may lead to aberrant differentiation.
In addition to changes in matrix deposition, a signiﬁcant increase
in the number of steroid receptor positive cells as well as the level
of expression was detected by immunostaining. At 10–12 weeks of
age, the steroid receptor expression changes from a pattern where it
is present in a high percentage of cells to a restrictedpattern (Silberstein
et al., 1996). This change in receptor expression pattern correlates with
a reduction in proliferation of the ductal epithelium (Clarke et al., 1997).
No difference in the proliferative capacity of themature ductal epitheli-
umwithin the wildtype and p190A-deﬁcient transplants was observed
in our studies, although this analysis could only be conducted on those
samples in which outgrowth had occurred. The approximately 50% re-
duction in percentage of fat pad ﬁlled in the EF transplants suggests
that the p190A deﬁcient mammary epithelium do grow at a reduced
rate. In addition, Rho GTPases and their regulators have been implicated
in estrogen dependent proliferation, invasion, and transcriptional acti-
vation in ER positive breast cancer cell lines (Barone et al., 2011; Su et
al., 2001; Walker et al., 2011; Xie and Haslam, 2008). It is intriguing to
speculate that Rho signaling proteins, including p190A, may also regu-
late ER dependent cellular processes in the developingmammary gland.
Further examination of the p190A-deﬁcient transplants also points
to p190A's putative role as a tumor suppressor. P190A-deﬁcient trans-
plants have a reduced myoepithelial cell layer. Myoepithelial cells se-
crete ﬁbronectin, collagen, nidogen, and laminin to form the basement
membrane. The reduction of myoepithelial cells may contribute to the
reduced collagen present in the stroma. Disruption of themyoepithelial
cell layer is also seen following p190B overexpression, which led to
hyperplastic lesions during pregnancy (Vargo-Gogola et al., 2006).
Previous studies have shown that overexpression of p190A
resulted in abnormal positioning of the cleavage furrow during cyto-
kinesis (Su et al., 2003), and that gene silencing of p190A was also
detrimental to cell cycle progression. These results, in combination
with data presented here implicating p190A in differentiation of the
mammary epithelium, may suggest a role for p190A in symmetric
versus asymmetric division of mammary progenitor cells. A defect in
symmetric versus asymmetric division may also potentially underlie
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Fig. 6. p190A deﬁciency disrupts mammary architecture and inhibits proper mammary gland differentiation. Immunohistochemical analysis of epithelial/myoepithelial cell layers with-
in the EF transplants. P63 immunostaining demonstrated discontinuity of the myoepithelial cell layer around the ducts of the p190A deﬁcient transplant (B) in comparison to wild-
type (A). Co-immunoﬂuorescence was performed for K14 (green)/K8 (red) to examine cell–cell connections between myoepithelial cells and epithelial cells respectively. Note the
elongated shape of the myoepithelial cell layer stained by K14 with no change in K8 between the wildtype (E) and p190A-deﬁcient (F) transplants.
9B.M. Heckman-Stoddard et al. / Developmental Biology 360 (2011) 1–10the aberrant differentiation of the mammary epithelium seen in the
p190A-deﬁcient outgrowths.
These studies have revealed a critical role for p190A in both the
epithelial and stromal compartments in the developing mammary
gland. Interestingly, three studies have implicated p190A as a tumor
suppressor (Tikoo et al., 2000; Wang et al., 1997; Wolf et al., 2003).
Our studies investigating p190B loss and gain of function in the
MMTV–Neu induced mammary tumor model suggest that p190B
functions as an oncogene during the stochastic process of mammary
tumorigenesis in vivo (Heckman-Stoddard et al., 2009; McHenry
et al., 2010) Future studies will be aimed at investigating the role of
p190A during mammary tumorigenesis.
Supplementary materials related to this article can be found
online at doi:10.1016/j.ydbio.2011.09.006.Acknowledgments
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